OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study
Arleigh McCurdy, Hsien Seow, Gregory R. Pond, et al.
Haematologica (2023) Vol. 108, Iss. 12, pp. 3384-3391
Open Access | Times Cited: 13
Arleigh McCurdy, Hsien Seow, Gregory R. Pond, et al.
Haematologica (2023) Vol. 108, Iss. 12, pp. 3384-3391
Open Access | Times Cited: 13
Showing 13 citing articles:
The Burden of Multiple Myeloma in China: Trends from 1990 to 2021 and Forecasts for 2050
Xuelin Dou, Guangcai Duan, You Zhong, et al.
Cancer Letters (2025) Vol. 611, pp. 217440-217440
Closed Access | Times Cited: 1
Xuelin Dou, Guangcai Duan, You Zhong, et al.
Cancer Letters (2025) Vol. 611, pp. 217440-217440
Closed Access | Times Cited: 1
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma
Raphael Lutz, Alexandra M. Poos, Llorenç Solé‐Boldo, et al.
Science Immunology (2025) Vol. 10, Iss. 104
Open Access | Times Cited: 1
Raphael Lutz, Alexandra M. Poos, Llorenç Solé‐Boldo, et al.
Science Immunology (2025) Vol. 10, Iss. 104
Open Access | Times Cited: 1
Ethanol extract of Eclipta prostrata induces multiple myeloma ferroptosis via Keap1/Nrf2/HO-1 axis
Wenxia Li, Xuejiao Yin, Hangjie Fu, et al.
Phytomedicine (2024) Vol. 128, pp. 155401-155401
Closed Access | Times Cited: 5
Wenxia Li, Xuejiao Yin, Hangjie Fu, et al.
Phytomedicine (2024) Vol. 128, pp. 155401-155401
Closed Access | Times Cited: 5
Multiple Myeloma: Improved Outcomes Resulting from a Rapidly Expanding Number of Therapeutic Options
Susanna Kim, Adam ElSayed, Jonathan E. Moore, et al.
Targeted Oncology (2025)
Closed Access
Susanna Kim, Adam ElSayed, Jonathan E. Moore, et al.
Targeted Oncology (2025)
Closed Access
Survival, years of life lost and attrition rates in multiple myeloma patients in France
Aurore Perrot, F. Raguideau, Hélène Denis, et al.
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Aurore Perrot, F. Raguideau, Hélène Denis, et al.
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Exploring the ocular involvement in multiple myeloma: a comprehensive review of 70-year clinical studies
Matteo Ripa, Chiara Schipa, Paola Aceto, et al.
International Ophthalmology (2025) Vol. 45, Iss. 1
Closed Access
Matteo Ripa, Chiara Schipa, Paola Aceto, et al.
International Ophthalmology (2025) Vol. 45, Iss. 1
Closed Access
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics
Mohamed Halaby Elbahoty, Bhavyasree Papineni, Rajeev S. Samant
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 6, pp. 829-842
Open Access | Times Cited: 2
Mohamed Halaby Elbahoty, Bhavyasree Papineni, Rajeev S. Samant
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 6, pp. 829-842
Open Access | Times Cited: 2
Treatment of elderly and frail myeloma patients
Steven Chun-Min Shih, Alissa Visram, Hira Mian
La Presse Médicale (2024), pp. 104266-104266
Open Access | Times Cited: 1
Steven Chun-Min Shih, Alissa Visram, Hira Mian
La Presse Médicale (2024), pp. 104266-104266
Open Access | Times Cited: 1
Pomalidomide Use and Kidney Outcomes in Patients with Relapsed/Refractory Multiple Myeloma and Chronic Kidney Disease: A Real-World, Population-Based Cohort Study
Alejandro Meraz Muñoz, Hira Mian, David H. Kirkwood, et al.
(2024)
Closed Access
Alejandro Meraz Muñoz, Hira Mian, David H. Kirkwood, et al.
(2024)
Closed Access
Percutaneous vertebroplasty/kyphoplasty contributes to the improved outcome in patients with newly diagnosed multiple myeloma: A single center cohort study
Fujing Zhang, Shuzhong Liu, Xi Zhou, et al.
Journal of bone oncology (2024) Vol. 47, pp. 100615-100615
Open Access
Fujing Zhang, Shuzhong Liu, Xi Zhou, et al.
Journal of bone oncology (2024) Vol. 47, pp. 100615-100615
Open Access
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial
Arleigh McCurdy, Donna Reece, Martha L Louzada, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access
Arleigh McCurdy, Donna Reece, Martha L Louzada, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access
Pomalidomide Use and Kidney Outcomes in Patients With Relapsed/Refractory Multiple Myeloma and Chronic Kidney Disease: A Real-World, Population-Based Cohort Study
Alejandro Meraz-Muñoz, Hira Mian, David H. Kirkwood, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 11, pp. e861-e869
Open Access
Alejandro Meraz-Muñoz, Hira Mian, David H. Kirkwood, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 11, pp. e861-e869
Open Access
